Full Text View
Tabular View
No Study Results Posted
Related Studies
Prospective, Multicentre, Open-Label Study Evaluating 1,5 mg/Day of Fondaparinux. (PROPICE)
This study has been completed.
Study NCT00555438   Information provided by Centre Hospitalier Universitaire de Saint Etienne
First Received: November 7, 2007   Last Updated: October 13, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Interventions listed in this trial
fondaparinux 1,5 mg/day
Additional drug interventions recognized in this trial
Fondaparinux
Org 31540
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Centre Hospitalier Universitaire de Saint Etienne
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services